ArticleActive
Billing and Coding: MolDX: Genetic Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)
A57571
Wisconsin Physicians Service Insurance Corporation (J05)
Effective: November 7, 2024
Updated: December 31, 2025
See LCD L36400Policy Summary
This billing/coding guidance complements MolDX LCD L36400 for genetic testing for hypercoagulability/thrombophilia (Factor V Leiden, Factor II prothrombin, MTHFR). Claims must report the appropriate CPT code with exactly 1 unit of service and include the appropriate DEX Z-Code identifier adjacent to the CPT in the specified Part A or Part B claim fields; do not add extra characters on SV101-7.
Coverage Criteria Preview
Key requirements from the full policy
"Genetic testing for hypercoagulability/thrombophilia (Factor V Leiden, Factor II prothrombin, and MTHFR) when clinically indicated as defined by MolDX LCD L36400."
Sign up to see full coverage criteria, indications, and limitations.